These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18727012)

  • 21. Arsonoliposomes for the potential treatment of medulloblastoma.
    Favretto ME; Marouf S; Ioannou P; Antimisiaris SG; Parker TL; Kallinteri P
    Pharm Res; 2009 Oct; 26(10):2237-46. PubMed ID: 19626426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physico-chemical properties and cytotoxicity assessment of PEG-modified liposomes containing human hemoglobin.
    Centis V; Vermette P
    Colloids Surf B Biointerfaces; 2008 Sep; 65(2):239-46. PubMed ID: 18538549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and properties of arsonolipid containing liposomes.
    Fatouros D; Gortzi O; Klepetsanis P; Antimisiaris SG; Stuart MC; Brisson A; Ioannou PV
    Chem Phys Lipids; 2001 Jan; 109(1):75-89. PubMed ID: 11163346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface modification of liposomes by saccharides: vesicle size and stability of lactosyl liposomes studied by photon correlation spectroscopy.
    Zhu J; Yan F; Guo Z; Marchant RE
    J Colloid Interface Sci; 2005 Sep; 289(2):542-50. PubMed ID: 15922349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of Novel Arsonolipids and Development of Novel Arsonoliposome Types.
    Mourtas S; Papadia K; Kordopati GG; Ioannou PV; Antimisiaris SG; Tsivgoulis GM
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.
    Mourtas S; Duraj S; Fotopoulou S; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):270-6. PubMed ID: 17928204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenolipids.
    Dembitsky VM; Levitsky DO
    Prog Lipid Res; 2004 Sep; 43(5):403-48. PubMed ID: 15458814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous domains and membrane permeability in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch.
    Karve S; Bajagur Kempegowda G; Sofou S
    Langmuir; 2008 Jun; 24(11):5679-88. PubMed ID: 18471003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disaccharide-modified liposomes and their in vitro intracellular uptake.
    Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H
    Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
    Wang Y; An R; Dong X; Pan S; Duan G; Sun X
    Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
    Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
    Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh PP; Burke TG; Ranjan D
    Int J Pharm; 2009 Jan; 366(1-2):133-9. PubMed ID: 18840516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone.
    Kawano K; Onose E; Hattori Y; Maitani Y
    Mol Pharm; 2009; 6(1):98-104. PubMed ID: 19072653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposome/DNA systems: correlation between association, hydrophobicity and cell viability.
    Chiaramoni NS; Speroni L; Taira MC; Alonso Sdel V
    Biotechnol Lett; 2007 Nov; 29(11):1637-44. PubMed ID: 17636387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells.
    Noratto G; Porter W; Byrne D; Cisneros-Zevallos L
    J Agric Food Chem; 2009 Jun; 57(12):5219-26. PubMed ID: 19530711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
    Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
    Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.
    Ajana I; Astier A; Gibaud S
    J Pharm Pharmacol; 2009 Oct; 61(10):1295-301. PubMed ID: 19814860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on tamoxifen encapsulated in lipid vesicles: effect on the growth of human breast cancer MCF-7 cells.
    Bhatia A; Bhushan S; Singh B; Katare OP
    J Liposome Res; 2009; 19(3):169-72. PubMed ID: 18991067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.